150 results on '"Roth, Arnaud D."'
Search Results
2. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study
3. supplementary Table S6 from BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
4. supplementary Figures from BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
5. supplementary Table S1 and S2 from BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
6. supplementary methods and legends from BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
7. Elective Inguinal Node Irradiation in Early-Stage T2N0 Anal Cancer: Prognostic Impact on Locoregional Control
8. Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal Cancer
9. Response
10. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
11. Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score
12. Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
13. Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle
14. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: A prospective study
15. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: A longitudinal prospective study
16. ‘Liver First’ Approach in the Treatment of Colorectal Cancer with Synchronous Liver Metastases
17. European experience of docetaxel and cisplatin in advanced gastric cancer
18. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial
19. Combining Capecitabine and Gemcitabine in Patients With Advanced Pancreatic Carcinoma: A Phase I/II Trial
20. OXALIPLATINE (OXA) COMBINED WITH IRINOTECAN (CPT-11) AND 5FU/LEUCOVORIN (OCFL) IN METASTATIC COLORECTAL CANCER (MCRC): A PHASE I-II STUDY: 570
21. Phase II Study of Capecitabine and Oxaliplatin in First- and Second-Line Treatment of Advanced or Metastatic Colorectal Cancer
22. Curative preoperative treatment with docetaxel (Taxotere®)-cisplatin-5FU (TCF) combined with hyperfractionated radiation therapy in locally advanced cancer of the esophagus: A phase I-II study.
23. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor : A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
24. Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy
25. Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
26. Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I–II trial
27. The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy
28. Response
29. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)
30. Long-Term Survival with Regorafenib in KRAS-Mutated Metastatic Rectal Cancer
31. BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
32. Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal Cancer
33. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
34. A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
35. Identification of a Poor-Prognosis BRAF-Mutant–Like Population of Patients With Colon Cancer
36. Node-negative T1–T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?
37. Phase I/II Study of Gefitinib and Concomitant Preoperative Radiotherapy in Patients with Locally Advanced Rectal Cancer
38. Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
39. Successful Closure of Anal Cancer-Related Fistulas With Upfront Intra-arterial Chemotherapy: a Report of 8 Cases
40. Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
41. Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
42. Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score
43. Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research
44. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: Long-term results of a phase I trial
45. Preoperative Concomitant Hyperfractionated Radiotherapy and Gemcitabine for Locally Advanced Rectal Cancers
46. Curative treatment of gastric cancer: towards a multidisciplinary approach?
47. Wilms' Tumor in the Adult — Report of a Case and Review of the Literature
48. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma
49. Spontaneous Retroperitoneal Hemorrhage due to Adrenal Metastasis for Non-Small Cell Lung Cancer Treated by Radiation Therapy
50. 13-cis-Retinoic Acid Plus Interferon-α: A Phase II Clinical Study in Squamous Cell Carcinoma of the Lung and the Head and Neck
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.